The working group negotiating amendments to the World Health Organization’s (WHO) International Health Regulations (WGIHR) has extended its seventh meeting, which was supposed to end last Friday, to include a special session on equity. The resumed WGIHR 7 will be held within the first two weeks of March, finally acceding to member state’s requests – […] Continue reading ->
 Evergreening patents on medical products – extending the lifespan of patents that are about to expire – is an “abuse of the intellectual property system”, an HIV activist told the World Health Organization’s (WHO) Fair Pricing Forum on Thursday. Meanwhile, an industry representative laid out her company’s value-based, country-specific approach to improving access to medicines, […] Continue reading ->
Over 50 civil society groups have written to the leaders of the world’s biggest medicine procurement programmes urging them to reject “secrecy clauses” in their agreements with pharmaceutical companies.  The letter, which has been shared exclusively with Health Policy Watch, was sent to the heads of UNICEF, the Pan American Health Organization (PAHO), vaccine alliance […] Continue reading ->
The high price of medicines in many high- and middle-income countries and ensuring medical supply chains during crises were  some of the issues discussed at the Fair Pricing Forum, which opened on Monday. The three-day forum, hosted by the World Health Organization’s (WHO), brings member states and stakeholders together to  discuss how to ensure “optimal access […] Continue reading ->
With only 10 official negotiating days left, the Working Group on Amendments to the International Health Regulations (WGIHR) is under pressure to reach agreement on changes to the rules that govern global health emergencies. The seventh WGIHR meeting which began on Monday officially kicked off the 2024 pandemic ‘season’ negotiations at the World Health Organization […] Continue reading ->
An alliance of conservative World Health Organization (WHO) member states and right-wing US organisations has halted the process of granting a reproductive health organisation “official relations” with the global body. Meanwhile, a similar member state grouping objected to the use of “WHO LGBTQI+ community” in a routine human resources report that the Director-General tabled at […] Continue reading ->